Facebook
X
LinkedIn
ForwardEarly Cancer Detection & Precision Cancer Management 2027
This course offers Live (in-person) and Livestream (virtual) attendance options
Course Directors: Aadel A. Chaudhuri, M.D., Ph.D., Steven W. Ressler, M.D., Jewel J. Samadder, M.D., Vamsi Velcheti, M.D.
April 23-24, 2027 - The Westin Carlsbad Resort & Spa - Carlsbad, CA
This course brings together academic and industry experts in early cancer detection. The goal of the course is to explore emerging innovations in multicancer detection (MCD) as a population screening tool, cell-free DNA (cfDNA), multimodal detection platforms, and precision cancer treatment. Leveraging Mayo Clinic’s integrated practice model, participants examine current advances, clinical applications, implementation challenges, and collaborative opportunities to accelerate innovation and improve cancer outcomes. Join leading academic, clinical, and industry experts to explore innovations that are transforming early cancer detection. This activity highlights advances in multicancer detection (MCD) as a population screening tool, cell-free DNA (cfDNA), multimodal detection platforms and precision cancer treatment and interception, while addressing clinical implementation, collaboration, and strategies to accelerate translation into practice.
| Registration Fee(s) | |
|---|---|
| M.D., D.O., Ph.D. - Live Course | $600 |
| M.D., D.O., Ph.D. - Livestream | $525 |
| Allied Health, NP, PA - Live | $450 |
| Allied Health, NP, PA - Livestream | $375 |
Target Audience
This course is designed for healthcare professionals involved in the care of early cancer detection and management which may benefit from this program.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the science behind MCD tests that utilize methylation patterns of cell-free tumor DNA to help identify presymptomatic cancer.
- Describe the currently available multicancer detection (MCD) tests used for population screening and key operating characteristics.
- Recognize the challenges associated with diagnostic evaluations of patients with abnormal MCD testing including emerging best practices for management of unconfirmed positive results.
- Describe the role of tumor genomic profiling in identifying actionable genomic alterations and informing precision oncology strategies.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Course summary
- 10.25 AAPA Category 1
- 10.25 AMA PRA Category 1 Credit™
- 10.25 ANCC
- 10.25 Attendance
Mayo Clinic Early Cancer Detection & Precision Cancer Management 2027 |
Carlsbad, California |
April 23-24, 2027 |
PST |
Day 1 | Friday, April 23, 2027 | |
7:00 AM |
7:55 AM | Registration, Breakfast and Exhibits |
7:55 AM |
8:00 AM | Announcements |
|
| Genomic Risk Assessment Moderator: Jewel J. Samadder, M.D. |
8:00 AM |
8:20 AM | Hereditary cancer risk Douglas L. Riegert-Johnson, M.D. |
8:20 AM |
8:40 AM | CHIP Mrinal S. Patnaik, M.B.B.S. |
8:40 AM |
9:00 AM | Population genomic sequencing: The TAPESTRY Trial Konstantinos N. Lazaridis, M.D. |
9:00 AM |
9:20 AM | Polygenic Risk Scores Victor E. Ortega, M.D., Ph.D. |
9:20 AM |
9:25 AM | Q&A Session |
|
| Early Cancer Detection Moderator: Steven W. Ressler, M.D. |
9:25 AM |
9:45 AM | Understanding the endpoints – is left shifting enough James R. Cerhan, M.D., Ph.D. |
9:45 AM |
10:05 AM | Single organ to multi-organ John B. Kisiel, M.D. |
10:05 AM |
10:25 AM | MCD Clinical Practice Ryan T. Hurt, M.D., Ph.D. |
10:25 AM |
10:45 AM | Whole Body MRI Kumar Sandrasegaran, M.B., Ch.B. |
10:45 AM |
11:05 AM | CLINICAL CASES PANEL DeAnna M. Weaver, APRN, C.N.P., M.S.N., Sarah A. Kroc, M.S., CGC, Ryan T. Hurt, M.D., Ph.D., John B. Kisiel, M.D., Rahul Pannala |
11:05 AM |
11:20 AM | Exhibits and Break |
|
| Multi-modal Cancer Detection Moderator: TBD |
11:20 AM |
11:40 AM | Multimodal AI for Early Cancer Detection: Breast and Pancreas Imon Banerjee, Ph.D. |
11:40 AM |
12:00 PM | Pathfinder 2 and NHS Galleri Karthik V. Giridhar, M.D. |
12:00 PM |
12:20 PM | AI and Digital Pathology in Cancer Andrew P. Norgan, M.D., Ph.D. |
12:20 PM |
12:35 PM | CLINICAL CASES PANEL Steven W. Ressler, M.D., Kumar Sandrasegaran, M.B., Ch.B., Prasad G. Iyer, M.D., M.S., Brian M. Dougan, M.D., Mrinal S. Patnaik, M.B.B.S. |
12:35 PM |
1:10 PM | Ahlquist Keynote Lecture 1 Maximilian Diehn – Guest Speaker (Stanford) |
1:10 PM |
1:55 PM | Lunch and Product Theatre 1 |
1:55 PM |
1:55 PM | Adjourn - General Session |
|
| Fireside with Industry Leaders Non CME Sessions |
2:00 PM |
2:15 PM | Single organ screening Guardant CMO |
2:15 PM |
2:30 PM | MCD Methylation vs Sequencing vs Proteins Exact CMO |
2:30 PM |
2:45 PM | MCD Lessons learned from NHS Galleri CMO |
2:45 PM |
3:00 PM | MCD with 5HMC sequencing Clearnote CMO |
3:00 PM |
3:20 PM | Q&A Session |
3:20 PM |
3:20 PM | Adjourn - Non CME Sessions |
Day 2 | Saturday, April 24, 2027 | |
7:00 AM |
7:55 AM | Breakfast and Exhibits/Product Theater |
7:55 AM |
8:00 AM | Announcements |
|
| Tumor Genomic Profiling Moderator - Vamsi Velcheti, M.D. |
8:00 AM |
8:20 AM | Moving from WES to WGS Benjamin R. Kipp, Ph.D. |
8:20 AM |
8:40 AM | Blood or Tumor or both Shenduo Li, M.D., Ph.D. |
8:40 AM |
9:00 AM | Neurological Cancers – CGP to MRD Gelareh Zadeh, M.D., Ph.D. |
9:00 AM |
9:10 AM | Q&A Session |
9:10 AM |
9:30 AM | CLINICAL CASES PANEL Tanios S. Bekaii-Saab, M.D., Aaron S. Mansfield, M.D., Katie M. Van Abel, M.D. |
|
| Recurrence Monitoring Moderator – John H. Strickler, M.D. |
9:30 AM |
9:50 AM | Discovery of MRD Biomarkers Aadel A. Chaudhuri, M.D., Ph.D. |
9:50 AM |
10:10 AM | Application of MRD in oncology practice John H. Strickler, M.D. |
10:10 AM |
10:30 AM | Evolving roles of MRD in radiation oncology David M. Routman, M.D. |
10:30 AM |
10:40 AM | Q&A Session |
10:40 AM |
11:00 AM | CLINICAL CASES PANEL Felipe Batalini, M.D., Elisabeth I. Heath, M.D., Christina S. Wu, M.B., B.Ch., M.D., Pooja P. Advani, M.B.B.S., M.D. |
11:00 AM |
11:20 AM | Exhibits and Break |
|
| Cancer Interception Moderator – TBD |
11:20 AM |
11:40 AM | Cancer Interception in lung – a success story? Jianjun Zhang, M.D. (MD Anderson) |
11:40 AM |
12:00 PM | Theranostics Geoffrey B. Johnson, M.D., Ph.D. or Ephraim E. Parent, M.D., Ph.D. |
12:00 PM |
12:20 PM | Interception of Pancreas Cancer - Cyst Surveillance and Ablation Shounak Majumder, M.D. |
12:20 PM |
12:30 PM | Q&A Session |
12:30 PM |
1:00 PM | Ahlquist Keynote Lecture 2 Charlie Swanton - (Cancer Research UK) |
1:00 PM |
1:55 PM | Lunch and Product Theatre 3 |
1:55 PM |
1:55 PM | Adjourn - General Session |
|
| Fireside with Industry Leaders Non CME Sessions |
2:00 PM |
2:15 PM | CGS Caris Assure Caris CMO |
2:15 PM |
2:30 PM | CGS Tempus Tempus CMO |
2:30 PM |
2:45 PM | MRD Natera Natera CMO |
2:45 PM |
3:00 PM | MRD Illumina Illumina CMO |
3:00 PM |
3:20 PM | QA |
3:20 PM |
3:20 PM | Adjourn - Non CME Sessions |
3:20 PM |
3:35 PM | Optional - California - Cultural and Linguistic Competency Module (Additional 0.5 credits) Darryl Chutka, M.D. |
All travel and lodging expenses are the sole responsibility of the individual registrant.
Course Directors:
Aadel A. Chaudhuri, M.D., Ph.D.
Steven W. Ressler, M.D.
Jewel J. Samadder, M.D.
Vamsi Velcheti, M.D.
Guest Faculty:
Maximilian Diehn, MD, PhD
Stanford Medicine Health Care
Palo Alto, California
Charles Swanton FRCP BSc PhD
Francis Crick Institute
London, United Kingdom
Jianjun Zhang, MD, PhD
The University of Texas MD Anderson Cancer Center
Houston, Texas
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statements:
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 10.25 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 10.25 AAPA Category 1
- 10.25 AMA PRA Category 1 Credit™
- 10.25 ANCC
- 10.25 Attendance
Thank you for your interest in the Early Cancer Detection & Precision Cancer Management 2027 course. This course is currently in the early planning stages. If you’d like to be notified when opportunities become available, please add your name to our Notify Me list. Signing up to be notified will ensure that you receive an email when exhibitor information is available. No additional information is available until then.
| Registration Fee(s) | |
|---|---|
| M.D., D.O., Ph.D. - Live Course | $600 |
| M.D., D.O., Ph.D. - Livestream | $525 |
| Allied Health, NP, PA - Live | $450 |
| Allied Health, NP, PA - Livestream | $375 |
Please update your profile to let us know if you have dietary restrictions or access requirements.
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Every effort will be made to accommodate dietary requirements; however, some requests may not be feasible based on venue kitchen capabilities. Attendees will be contacted in advance if a dietary restriction cannot be fulfilled.
The Mayo Clinic School of Continuous Professional Development strives for fully accessible learning experiences. If you anticipate any barriers while attending this course, please reach out to the course coordinator who will be in touch with all registrants. If you need disability-related accommodations, please contact the Office of Wellness and Academic Support – Disability Access Services at MCCMS.DS@mayo.edu.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.